Correlation Between Unicycive Therapeutics and Ocean Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Ocean Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Ocean Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Ocean Biomedical, you can compare the effects of market volatilities on Unicycive Therapeutics and Ocean Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Ocean Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Ocean Biomedical.

Diversification Opportunities for Unicycive Therapeutics and Ocean Biomedical

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Unicycive and Ocean is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Ocean Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocean Biomedical and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Ocean Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocean Biomedical has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Ocean Biomedical go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and Ocean Biomedical

Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.51 times more return on investment than Ocean Biomedical. However, Unicycive Therapeutics is 1.51 times more volatile than Ocean Biomedical. It trades about 0.03 of its potential returns per unit of risk. Ocean Biomedical is currently generating about -0.09 per unit of risk. If you would invest  78.00  in Unicycive Therapeutics on September 5, 2024 and sell it today you would lose (7.00) from holding Unicycive Therapeutics or give up 8.97% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Unicycive Therapeutics  vs.  Ocean Biomedical

 Performance 
       Timeline  
Unicycive Therapeutics 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Ocean Biomedical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ocean Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Unicycive Therapeutics and Ocean Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Unicycive Therapeutics and Ocean Biomedical

The main advantage of trading using opposite Unicycive Therapeutics and Ocean Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Ocean Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocean Biomedical will offset losses from the drop in Ocean Biomedical's long position.
The idea behind Unicycive Therapeutics and Ocean Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Transaction History
View history of all your transactions and understand their impact on performance